Clinical trial establishes Lankenau as one of the most comprehensive heart valve centers nationally by offering yet another alternative to open-heart surgery
News | Structural Heart
Lankenau Medical Center Performs First Minimally Invasive Procedure for Aortic Regurgitation in Philadelphia Region

June 22, 2023 — Lankenau Medical Center, part of Main Line Health, has performed the first minimally invasive catheter ...

Home June 22, 2023
Home
The Society of Interventional Radiology (SIR) published a new position statement offering recommendations on the management of chronic iliofemoral venous obstruction with endovascular placement of metallic stents.
News | Interventional Radiology
Newly Published Society of Interventional Radiology Position Statement Outlines Appropriate Use of Endovascular Management for Treatment of Chronic Iliofemoral Venous Occlusions

June 22, 2023 — The Society of Interventional Radiology (SIR) published a new position statement offering ...

Home June 22, 2023
Home
The Midwest company will begin offering EchoSolv, an artificial intelligence clinical decision support platform designed to help detect severe aortic stenosis, to providers throughout the country.
News | Artificial Intelligence
Cassling Connects Cardiologists with Revolutionary AI Software

June 22, 2023 — Cassling has announced a partnership with the goal of benefiting cardiovascular practices throughout the ...

Home June 22, 2023
Home
Developed in collaboration with Mayo Clinic, with support from Pfizer, this ECG-AI algorithm aims to aid physicians in earlier identification of cardiac amyloidosis
News | ECG
Anumana Receives U.S. FDA Breakthrough Device Designation for its Cardiac Amyloidosis Algorithm

June 21, 2023 — Anumana, Inc., a leading AI-driven health technology company, has received Breakthrough Device ...

Home June 21, 2023
Home
Qardio, a leading innovator in healthcare technology, has unveiled its groundbreaking Livestream solution suite, which includes continuous ECG, Blood Pressure, Pulse Oximetry (SPO2), Body Temperature, Weight, and Body Position monitoring
News | Remote Monitoring
Qardio Introduces Revolutionary Livestream ECG Monitoring and Advances Healthcare

June 21, 2023 — Qardio, a leading innovator in healthcare technology, has unveiled its groundbreaking Livestream ...

Home June 21, 2023
Home
Qardio, a leading innovator in healthcare technology, has unveiled its groundbreaking Livestream solution suite, which includes continuous ECG, Blood Pressure, Pulse Oximetry (SPO2), Body Temperature, Weight, and Body Position monitoring
News | Cath Lab
Philips and BIOTRONIK Expand Care for Out-of-hospital Cardiology Labs with New Strategic Alliance

June 21, 2023 — Royal Philips, a global leader in health technology, announced it has teamed up with BIOTRONIK (Lake ...

Home June 21, 2023
Home
DAIC AHA Statement PAD June
News | Peripheral Artery Disease (PAD)
American Heart Association Releases Scientific Statement on Reducing Disparities in Peripheral Artery Disease with Routine Tests

June 21, 2023 — A new science report issued by the American Heart Association (AHA) emphasizes the importance of ...

Home June 21, 2023
Home
The US Food and Drug Administration has approved the use of iTFlow in blood flow analysis. The FDA approval is significant as it recognizes the safety and effectiveness of iTFlow in analyzing blood flow through 4D Flow MRI data, with the potential to enhance diagnostic accuracy for patients with cardiovascular diseases and heart conditions.
News | Magnetic Resonance Imaging (MRI)
FDA Approves Innovative 4D Flow MRI Blood Flow Analysis Software from Cardio Flow Design Inc.

June 20, 2023 — The US Food and Drug Administration has approved the use of iTFlow in blood flow analysis. The FDA ...

Home June 20, 2023
Home
LODOCO (colchicine, 0.5 mg tablet) Reduces Cardiac Event Risk in Adult Patients with Established Atherosclerotic Cardiovascular Disease (ASCVD) by an Additional 31% on Top of Standard of Care
News | Pharmaceuticals
U.S. FDA Approves First Anti-Inflammatory Drug for Cardiovascular Disease

June 20, 2023 — AGEPHA Pharma USA, LLC, announced that, following a Priority Review, the U.S. Food and Drug ...

Home June 20, 2023
Home
Screen Shot 2023-06-20 at 10.25.26 AM
News | Artificial Intelligence
Advanced Medical Algorithm-based Chatbot, Pāṇini, Revolutionizes Clinical Outcomes

June 20, 2023 — Pāṇini, an AI-powered chatbot developed by doctors for doctors, has officially launched, aiming to ...

Home June 20, 2023
Home
Patients who had heart attacks during the first COVID-19 lockdown in the UK and Spain are predicted to live 1.5 and 2 years less, respectively, than their pre-COVID counterparts.
News | Coronavirus (COVID-19)
One Month of COVID-19 Lockdown Cost Heart Attack Patients Up to Two Years of Life

June 19, 2023 — Patients who had heart attacks during the first COVID-19 lockdown in the UK and Spain are predicted to ...

Home June 19, 2023
Home
Luscii Virtual Heart Clinic aims to provide cardiologists with a comprehensive, easy-to-use app to offer remote cardiac patient monitoring to their patients. The app prompts patients to take measurements of vital signs which are automatically analysed to detect abnormalities.
News | ECG
AliveCor Collaborates with European Market Leader in Remote Patient Monitoring Luscii to Offer World's First 'Virtual Heart Clinic in a Box'

June 19, 2023 — AliveCor, a global leader in personal electrocardiogram (ECG) technology, has announced a groundbreaking ...

Home June 19, 2023
Home
Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted approval for the DETOUR System to treat patients with complex peripheral arterial disease (PAD).
News | Peripheral Artery Disease (PAD)
Endologix Announces 24-Month Results of DETOUR- 2 Study at 2023 Vascular Annual Meeting

June 16, 2023 — Endologix LLC, a privately held, global medical device company, dedicated to providing disruptive ...

Home June 16, 2023
Home
Out-of-hospital cardiac arrests (OCHA) cause significant mortality and morbidity, and the study is one the largest trials ever conducted on cardiac arrest patients admitted to intensive care units (ICU).
News | Cardiovascular Clinical Studies
New Data from Global TAME Study Supports Current Management of CO2 Levels in Cardiac Arrest Patients

June 16, 2023 — A promising emerging treatment (hypercapnia) for comatose adult cardiac arrest patients has been found ...

Home June 16, 2023
Home
bempedoic_acid_Nexletor_Esperion
News | Cardiovascular Clinical Studies
Esperion Presents Results from New Analysis on Cardiovascular Benefits with Bempedoic Acid Treatment at ENDO 2023

June 16, 2023 — Esperion presented results from an analysis comparing the cardiovascular risk reduction benefits of ...

Home June 16, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now